Streptococcus pneumoniae meningitis in children: Should initial antibiotic treatment be changed?;MENINGITIS A PNEUMOCOQUE DE L'ENFANT: FAUT-IL MODIFIER L'ANTIBIOTHERAPIE PROBABILISTE DES MENINGITES COMMUNAUTAIRES?

Archives de Pediatrie

Volumn 3, Issue 5, 1996, Pages 419-426

  Le Masne, A ^a   Gaillard, J L ^a   Lacaille, F ^a   Pron, B ^a   Labenne, M ^a   Silly, C ^a   Cheron G ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

antibiotics; child; drug resistance, microbial; meningitis, pneumococcal

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; CEFADROXIL; CEFTRIAXONE; CHLORAMPHENICOL; CLAVULANIC ACID; DEXAMETHASONE; JOSAMYCIN; NETILMICIN; RIFAMPICIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; GENTAMICIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGITIS; STREPTOCOCCUS PNEUMONIAE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; DRUG COMBINATION; PENICILLIN RESISTANCE; PROBABILITY; RETROSPECTIVE STUDY;

ADOLESCENT; AMIKACIN; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; HUMANS; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; NETILMICIN; PENICILLIN RESISTANCE; PROBABILITY; RETROSPECTIVE STUDIES;

EID: 0029978468     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-693X(96)86398-6     Document Type: Article

References (49)

1. Booy R, Moxon ER, Mac Farlane JA, Mayon-White RT, Slack MP. Efficacy of Haemophilus influenzae type b conjugate vaccine in Oxford region. Lancet 1992;340:847
2. Vadheim CM, Greenberg DP, Eriksen E, et al. Eradication of Haemophilus influenzae type b disease in Southern California. Arch Pediatr Adolesc Med 1994;148:51-6
3. Peltola H, Kilpi T, Antilla M. Rapid disapearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992;340:592-4
4. Cohen R, Reinert P, Geslin P. Évolution de la résistance aux antibiotiques du pneumocoque. Arch Fr Pédiatr 1992;49:77-9
5. Tan TQ, Mason EO Jr, Kaplan SL. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics 1992;90:928-33
6. Willett LD, Dillon HC Jr, Gray BM. Penicillin-intermediate pneumococci in a children's hospital. Am J Dis Child 1985;139:1054-7
7. Bingen E, Bourrillon A. Méningites purulentes du nourrisson. Est-il urgent de modifier le traitement de première intention ? Presse Méd 1994;23:763
8. Friedland IR, Mac Cracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82
9. Cohen R, De La Rocque F, Varon E, Geslin P. Antibiothérapie de première intention des méningites communautaires. Pédiatrie 1993;48:37-49
10. Mac Cracken GH Jr. Current management of bacterial meningitis in infants and children. Pediatr Infect Dis J 1992;11:169-74
11. Alonso J, Madrigal V, Garcia-Fuentes M. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin [Letter]. Pediatr Infect Dis J 1991;10:256
12. Asensi F, Perez-Tamarit D, Otero MC et al. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus [Letter]. Pediatr Infect Dis J 1989;8:895
13. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J 1991;10:871-3
14. Friedland IR, Shelton S, Paris M et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1993;12:196-200
15. Guibert M, Rehel P, Barre C, Odièvre M, Labrune P. Méningite à pneumocoque résistant au cefotaxime : deux observations [Abstract]. Arch Pédiatr 1994;1:405
16. John CC. Treatment failure with use of a third-generatìon cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994;18:188-93
17. Sloas MM, Barrett FF, Chesney PJ et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992;11:662-6
18. Geslin P, Fremaux A, Sissia G. Méningites à pneumocoque résistant à la pénicilline observées par le Réseau National de Surveillance des Infections Pneumococciques de 1987 à 1992. In : Infections à pneumocoque de sensibilité diminuée aux β-lactamines. Paris : Springer Verlag, 1993:109-20
19. Gaillard JL, Silly C, Le Masne A et al. Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis. Antimicrob Agents Chemother 1995;39:253-5
20. Yogev R, Kolling WM. Intraventricular levels of amikacin after intravenous administration. Antimicrob Agents Chemother 1981;20:583-6
21. Geslin P, Fremaux A, Sissia G et al. Étude de 64 méningites de l'enfant à Streptococcus pneumoniae résistant à la pénicilline. Réseau national de surveillance des infections pneumococciques (1987-1994). Méd Mal Infect 1994;24 (no spécial):986-97
22. Boucot I, Berche P. Les pneumocoques de sensibilité anormale à la pénicilline G. Méd Mal Infect 1992;22:833-7
23. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96
24. Smith JM, Dowson CG, Spratt BG. Localized sex in bacteria. Nature 1991;349:29-31
25. Linares J, Alonso T, Perez JL et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992;30:279-88
26. Geslin P. Résistance du pneumocoque aux antibiotiques. BEH 1992;7:29-31
27. Viladrich PF, Gudiol F, Linares J Rufi G, Ariza J, Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med 1988;84:839-46
28. Cherubin CE, Eng RHK, Norby R, Modai J, Humbert G, Overturf G. Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis 1989;11:526-48
29. Sande MA. Antibiotic therapy of bacterial meningitis: lessons we've learned. Am J Med 1981;71:507-10
30. Mac Cracken GH Jr, Sakata Y. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob Agents Chemother 1985;27:141-5
31. Tan TQ, Schutze GE, Mason EO Jr, Kaplan SL. Antibiotic therapy and outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1994;38:918-23
32. Gaillard JL, Abadie V, Chéron G et al. Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob Agents Chemother 1994;38:1209-10
33. Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, Mc Kracken GH. Effect of dexamethasone on therapy of experimental penicillin-and-cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994;38:1320-4
34. Schaad UB, Suter S, Gianella-Borradori A et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990;322:141-7
35. Viladrich PF, Gudiol F, Linares J et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991;35:2467-72
36. Friedland IR, Istre GR. Management of penicillin-resistant pneumococcal infections. Pediatr Infect Dis J 1992;11:433-5
37. Leggiadro RJ. Penicillin-and cephalosporin-resistant Streptococcus pneumoniae: an emerging microbial threat. Pediatrics 1994;93:500-3
38. Dossou-Gbete, Levy B, Weber M, Weber P, Gérard A. Méningite à pneumocoque résistant à la pénicilline : traitement par l'imipénème. Méd Mal Infect 1994;24:275-6
39. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis. Lancet 1989;i:1281-7
40. Friedland IR, Shelton S, Mc Cracken GH Jr. Chloramphenicol in penicillin-resistant pneumococcal meningitis. Lancet 1993;342:240-1
41. Barakett V, Lesage D, Delisle F et al. Activité bactériostatique et cinétique de bactéricidie de huit antibiotiques vis-à-vis de sept souches de pneumocoques résistants à la pénicilline G. Pathol Biol 1992;40:483-91
42. Bonacorsi S, Doit C, Bingen E. Activité bactéricide de 5 antibiotiques et de leurs associations aux concentrations obtenues in vivo dans le LCR, vis-à-vis de Streptococcus pneumoniae de sensibilité anormale à la pénicilline G [Abstract]. RICAI 1993;177/P10:177
43. Friedland IR, Paris M, Ehrett S, Hickey S, Olsen K, Mc Cracken GH. Evaluation of antimicrobial regimens for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993;37:1630-6
44. Barois A, Estournet B, Moranne JB, Piliot J, Chabenat C, Bataille J. Infections ventriculaires à staphylocoque. Traitement par vancomycine en perfusion veineuse continue. Presse Méd 1986;15:1805
45. Hawley HB, Gump DW. Vancomycin therapy of bacterial meningitis. Am J Dis Child 1973;126:261
46. Aujard Y, Bedu A, Baumann C, Bingen E. Traitement des méningites bactériennes du nouveau-né et de l'enfant. Rev Prat (Paris) 1994;44:2157-62
47. Astruc J. Méningites à pneumocoque de l'enfant. Propositions thérapeutiques. Méd Mal Infect 1994;24 (no spécial):982-5
48. Bray P, Varon E, Renier JL, Ghnassia JC, Pangon B. Bactéricidie de l'association céfotaxime-fosfomycine sur les pneumocoques de sensibilité diminuée à la pénicilline [Abstract]. RICAI 1991;18/C12:165
49. Haynes J, Hawkey PM, Williams EW. The in-vitro activity of combinations of penicillin and gentamicin against penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae. J Antimicrob Chemother 1986;18:426-8